Papers in EJC Skin Cancer
Page 3 · newest first
- Sonidegib reduced tumor burden in patients with advanced basal cell carcinoma in the BOLT trial: Long-term analysis resultsEJC Skin Cancer · 2024
- CDA deficiency is not associated with higher sensitivity to immune checkpoint inhibitors in melanoma patientsEJC Skin Cancer · 2024
- Comparison of the efficacy of skin examination using 3D total body photography to clinical and dermoscopic examinationEJC Skin Cancer · 2024
- Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective studyEJC Skin Cancer · 2024
- LASSO logistic regression reveals a mixed MiRNA and serum-marker classifier for prediction of immunotherapy response in liquid biopsies of melanoma patientsEJC Skin Cancer · 2024
- Clinical utility of comprehensive genomic profiling for skin cancer: A cohort study of 522 cases in a Japanese real-world settingEJC Skin Cancer · 2024
- Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic reviewEJC Skin Cancer · 2024
- Electronic patient-reported outcomes, fever management, and symptom prediction among patients with BRAF V600 mutant stage III–IV melanoma: The Kaiku Health platformEJC Skin Cancer · 2024
- Adjuvant radiotherapy for pleomorphic dermal sarcomaEJC Skin Cancer · 2024
- Morphometric differences between basal cell carcinomas & melanomas of the head & neck versus other sites and their influence on neural networksEJC Skin Cancer · 2024
- Hidden beneath the surface: Atypical presentation of Desmoplastic Melanoma in the teledermatology eraEJC Skin Cancer · 2024
- Quality of life issues faced by patients with keratinocyte cancer: A systematic reviewEJC Skin Cancer · 2024
- Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)?EJC Skin Cancer · 2024
- Independent association of sex, age and the melanoma subtype with histological regression in invasive melanomas: A retrospective studyEJC Skin Cancer · 2024
- Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort studyEJC Skin Cancer · 2024
- Desmoplasia, a risk factor for recurrence and metastasis in cutaneous squamous cell carcinoma: an interobserver agreement study among dermatopathologistsSHILAP Revista de lepidopterología · 2024
- Integrated transcriptomics reveals cellular and molecular interactions in pruritic cutaneous T-cell lymphomaSHILAP Revista de lepidopterología · 2024
- Insights on different erythroderma features in Sezary syndrome: a prospective validation studySHILAP Revista de lepidopterología · 2024
- Adverse Effects in Elderly Patients (≥ 85 years old) with Advanced Basal Cell Carcinoma Treated with Sonidegib: A multicenter retrospective studyEJC Skin Cancer · 2024
- Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA ConsortiumEJC Skin Cancer · 2024
- Patient with metatypical metastatic Basal Cell Carcinoma treated with VismodegibEJC Skin Cancer · 2024
- InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanomaEJC Skin Cancer · 2024
- Preoperative evaluation of high-risk basal cell carcinoma with line-field confocal optical coherence tomography (LC-OCT) reduces Mohs micrographic surgery stage number: A case-control studyEJC Skin Cancer · 2023
- Histologic and genomic characterization of a primary mucinous carcinoma of the skinSHILAP Revista de lepidopterología · 2023
- Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: A retrospective, multicentre cohort study from the NetherlandsEJC Skin Cancer · 2023
- Management of patients with skin adnexal carcinomasEJC Skin Cancer · 2023
- German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023EJC Skin Cancer · 2023
- A systematic review of economic evaluations for the interventions of superficial basal cell carcinomaEJC Skin Cancer · 2023
- CLAUDIUS Study: Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma – A retrospective multicenter study and literature reviewEJC Skin Cancer · 2023